[Imatinib therapy for patients with chronic myelogenous leukemia]. [electronic resource]
Producer: 20050401Description: 297-303 p. digitalISSN:- 0385-0684
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Hematopoietic Stem Cell Transplantation
- Humans
- Imatinib Mesylate
- Interferon-alpha -- administration & dosage
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Philadelphia Chromosome
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Remission Induction
No physical items for this record
Publication Type: English Abstract; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.